A comparison of the immunogenicity of intravenous BAT1806, a tocilizumab biosimilar, and its reference product (Rheumatology and Therapy, 2025)

(untitled) - Ebbers, HC; Taylor, PC; Leng, X; Wei, W; Kinsella, NM; Zhou, Y; Yang, X; Chamberlain, P